IRIX Earnings Date & History
IRIDEX Corp (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 4:07 PM ET
IRIDEX Corp
Health Care
- Next earnings date
- Monday, November 9, 2026
- Reporting session
- Time TBD
- EPS estimate
- $-0.02
- Revenue estimate
- $13.2M
IRIX earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Tuesday, August 18, 2026 | Q2 2026 | $-0.01 | $-0.07 | -586.3% | $12.6M |
| Tuesday, May 19, 2026 | Q1 2026 | $-0.07 | $-0.03 | +58.0% | $11.8M |
| Thursday, March 26, 2026 | Q4 2025 | $-0.02 | $-0.01 | +51.0% | $14.7M |
| Tuesday, November 11, 2025 | Q3 2025 | $-0.06 | $-0.09 | -47.1% | $12.5M |
| Tuesday, August 12, 2025 | Q2 2025 | $-0.09 | $-0.06 | +34.6% | $13.6M |
What the market is watching in IRIX's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next IRIX earnings date?
- IRIDEX Corp is scheduled to report on Monday, November 9, 2026 (Time TBD). Dates can change until the company confirms them.
- Does IRIX report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for IRIX?
- Consensus EPS for the upcoming quarter is $-0.02, on revenue of $13.2M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
IRIX earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.